Adoption of New Glucose-Lowering Medications in the US
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes Technology & Therapeutics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Adoption of New Glucose-Lowering Medications in the U.S. – The Case of SGLT2 Inhibitors: Nationwide Cohort Study
Diabetes Technol. Ther. 2019 Dec 01;21(12)702-712, RG McCoy, HJ Dykhoff, L Sangaralingham, JS Ross, P Karaca-Mandic, VM Montori, ND ShahFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.